**Core Concept**
Type 3 hypersensitivity reactions involve the formation of antigen-antibody complexes (immune complexes) that accumulate in various tissues, leading to an inflammatory response. These complexes can activate the complement system, attracting neutrophils and macrophages, which cause tissue damage through the release of enzymes and reactive oxygen species.

**Why the Correct Answer is Right**
In Type 3 hypersensitivity, the immune complexes are usually soluble but can deposit in tissues, triggering an inflammatory response. The complement system is activated, and the subsequent release of anaphylatoxins (C3a and C5a) attracts neutrophils and macrophages to the site of immune complex deposition. These cells release enzymes and reactive oxygen species, causing tissue damage. This process is often seen in conditions such as systemic lupus erythematosus (SLE), where autoantibodies form immune complexes that deposit in various tissues.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because Type 1 hypersensitivity reactions involve IgE antibodies binding to mast cells and basophils, leading to the release of histamine and other mediators, causing allergic symptoms.

**Option B:** This option is incorrect because Type 2 hypersensitivity reactions involve IgG or IgM antibodies binding to cell surface antigens, leading to cell destruction through mechanisms such as complement activation or antibody-dependent cellular cytotoxicity.

**Option C:** This option is incorrect because Type 4 hypersensitivity reactions involve T-cell mediated responses, often seen in delayed-type hypersensitivity reactions such as contact dermatitis or tuberculin skin testing.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that Type 3 hypersensitivity reactions can be caused by various factors, including infections, autoimmune diseases, and the administration of certain medications. Identifying the underlying cause is crucial for effective treatment and management.

**Correct Answer: C.**